![](images/Newspaper.gif)
Burden of Hepatitis B Virus at a Tertiary Care Hospital, Doda, Jammu and Kashmir, India: A Cross-sectional Study
DC05-DC08
Correspondence
Dr. Sameera Akhtar,
Demonstrator, Department of Microbiology, Government Medical College, Doda, Jammu and Kashmir, India.
E-mail: sameerazargar@gmail.com
Introduction: Hepatitis B Virus (HBV) causes most frequent chronic liver disease of infectious origin in human beings worldwide, with more than 600,000 deaths caused by end-stage liver disease complications per year. The most used test for identifying acute HBV infections and carriers is the detection of HBsAg. Immunochromatography assays have been suggested for routine use in clinical microbiology laboratories for the detection of HBsAg since they are easy to use, affordable, don’t need specialised equipment, and are straightforward to run. Compared to commercially available HEPA card kit for the detection of the same markers, Enzyme Linked Immunosorbent Assay (ELISA) was shown to be more sensitive for the detection of HBsAg. This study is first of its kind in District Doda, Jammu and Kashmir, India.
Aim: To know the burden of HBV in a Tertiary Care Hospital, Government Medical College, Doda using HEPA card kit and ELISA method.
Materials and Methods: The present hospital-based cross-sectional study was carried out in the Department of Microbiology, Government Medical College and Hospital, Doda Jammu and Kashmir, India during the period from January 2020 to December 2020. The study comprised blood samples from all age groups referred by clinical departments for testing HBsAg. Tests were performed using an immunochromatographic technique (HEPA card Diagnostic enterprises) for the qualitative detection of HBsAg, and results were interpreted in accordance with the manufacturer’s guidelines. The collected data was analysed in Microsoft excel sheet using Chi-square test to know the burden of HBV infection.
Results: Among total number of 5,448 samples tested, 50 (0.92%) were positive for HBsAg which comes under low epidemicity (<2%) as per World Health Organisation (WHO) guidelines. The number of positive females and males were 30 (0.84%) and 20 (1.07%), respectively. Females were predominate over males and majority of the positive patients (N=29) were younger than 40 years though prevalance (2.1%) was higher in age group above 40 years. All samples which shows positive by rapid test were also shown positive by ELISA test.
Conclusion: Overall prevalence of HBV was 0.92% which comes under low epidemicity (<2%) as per WHO guidelines. It can be an alternate option for community based studies and also helps to improve the public health and to prevent the spreading of disease in the local population.